Abiopharma

🔍 Folse Mark P. (Director)

Company: Business First Bancshares, Inc. (BFST)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 1,016 shares of COMMON STOCK (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 54,302.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 998 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,014.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 1,016 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 998.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: Reflects the grant of time-based restricted stock units to the reporting person under the Business First Bancshares, Inc. 2024 Equity Incentive Plan on June 25, 2026. The time-based restricted stock units will fully vest on June 25, 2027. Each time-based restricted stock unit is economically equivalent to one share of common stock of the issuer. Under the terms of the relevant restricted stock unit grant, the reported unvested restricted stock units are subject to forfeiture upon the occurrence of certain events.
• F2: The reporting person received an award of 1,016 time-based restricted stock units on June 26, 2025, vesting on the first anniversary of the issuance date.